Status:
UNKNOWN
Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/Depression
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Collaborating Sponsors:
Laboratoire de psychologie EA 3188
Centre Hospitalier Universitaire Dijon
Conditions:
Alzheimer Disease
Depression
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The global aim of our study is to validate eye movement recording as an early differential diagnostic tool, in order to discriminate as early as possible between neurodegenerative dementias of Alzheim...
Eligibility Criteria
Inclusion
- subject whose visual acuity \> 9/10
- subject without a diagnosis of eye disease
- subject without a neuropsychological sequelae
- for depressed patients :subject with a diagnosis of depression confirmed by a psychiatric evaluation and MADRS (Montgomery and Asberg Depression Rating Scale) score \>25 and without cognitive impairment or any other psychiatric pathology and MMSE (Mini Mental State Examination)≥18 and without symptoms of AD
- for Alzheimer patients :subject with AD diagnosed according to NINCDS-ADRDA (National Institute of Neurological and Communicative Disorders and Stroke -Alzheimer's Disease and Related Disorders Association) criteria and MMSE ≥18 and without psychiatric disorder and MADRS score \< 25
- for control patients : subject without AD, depression or any other psychiatric condition identified by the diagnostic criteria or cognitive disorders and MADRS score \<25 and MMSE \> 20
Exclusion
- subject age under 60
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2018
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT01434940
Start Date
April 1 2010
End Date
July 1 2018
Last Update
July 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univserity Hospital of Besançon - Psychiatry Department
Besançon, France, 25000